Identification of caffeoylquinic acid derivatives as natural protein tyrosine phosphatase 1B inhibitors from Artemisia princeps

Bioorg Med Chem Lett. 2018 Apr 15;28(7):1194-1197. doi: 10.1016/j.bmcl.2018.02.052. Epub 2018 Mar 6.

Abstract

Considerable attention has been paid to protein tyrosine phosphatase 1B (PTP1B) inhibitors as a potential therapy for diabetes, obesity, and cancer. Ten caffeoylquinic acid derivatives (1-10) from leaves of Artemisia princeps Pamp. (Asteraceae) were identified as natural PTP1B inhibitors. Among them, chlorogenic acid (3) showed the most potent inhibitory activity (IC50 11.1 μM). Compound 3 was demonstrated to be a noncompetitive inhibitor by a kinetic analysis. Molecular docking simulation suggested that compound 3 bound to the allosteric site of PTP1B. Furthermore, compound 3 showed remarkable selectivity against four homologous PTPs. According to these findings, compound 3 might be potentially valuable for further drug development.

Keywords: Artemisia princeps; Caffeoylquinic acid; Chlorogenic acid; Protein tyrosine phosphatase 1B.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Artemisia / chemistry*
  • Dose-Response Relationship, Drug
  • Humans
  • Molecular Docking Simulation
  • Molecular Structure
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1 / antagonists & inhibitors*
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1 / metabolism
  • Quinic Acid / analogs & derivatives*
  • Quinic Acid / chemical synthesis
  • Quinic Acid / chemistry
  • Quinic Acid / pharmacology
  • Structure-Activity Relationship

Substances

  • caffeoylquinic acid
  • Quinic Acid
  • PTPN1 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1